Radiotherapy plus Long-term Adjuvant Androgen Deprivation with a Luteinizing Hormone-releasing Hormone Antagonist Versus Agonist in Patients with Very High-risk Localized or Locally Advanced Prostate Cancer: The EORTC GUCG-1414 Phase 3 Randomized Trial.

Auteurs

Zilli T, Böhmer D, Roeder A, Lauffer D, Villafranca Iturre AE, Jové-Teixidó JJ, Supiot S, Latorzeff I, Dirix P, Otte FX, Francolini G, Roumeguère T, Simon JM, Fournier B, Fortpied C, Lara PC, Tombal B

  • Date de publication

    November 2025

  • Type

    Article

  • Review

    Eur Urol Oncol

  • Researcher's name

    OTTE FRANCOIS-XAVIER

  • Hôpital

    Institut Jules Bordet

  • Service

    Radiothérapie

  • PMID

    41206286

  • DOI

    10.1016/j.euo.2025.10.009